In the latest session, Petros Pharmaceuticals Inc (NASDAQ: PTPI) closed at $1.07 down -23.57% from its previous closing price of $1.40. In other words, the price has decreased by -$0.3300 from its previous closing price. On the day, 2007623 shares were traded.
Ratios:
For a deeper understanding of Petros Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.71 and its Current Ratio is at 3.02. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 1.05.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTPI now has a Market Capitalization of 2.36M and an Enterprise Value of -6.93M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.34 while its Price-to-Book (P/B) ratio in mrq is 0.33. Its current Enterprise Value per Revenue stands at -0.99 whereas that against EBITDA is 0.79.
Stock Price History:
Over the past 52 weeks, PTPI has reached a high of $9.54, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is 1.4344, while the 200-Day Moving Average is calculated to be 1.8523.
Shares Statistics:
For the past three months, PTPI has traded an average of 1.06M shares per day and 806.01k over the past ten days. A total of 2.99M shares are outstanding, with a floating share count of 1.31M. Insiders hold about 40.34% of the company’s shares, while institutions hold 5.30% stake in the company. Shares short for PTPI as of Mar 15, 2024 were 88.39k with a Short Ratio of 0.08, compared to 282.4k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.02% and a Short% of Float of 6.43%.
Earnings Estimates
There are 1 different market analysts currently analyzing its stock. The consensus estimate for the next quarter is -$1.19, with high estimates of -$1.19 and low estimates of -$1.19.
Analysts are recommending an EPS of between -$5.15 and -$5.15 for the fiscal current year, implying an average EPS of -$5.15. EPS for the following year is -$5.01, with 1 analysts recommending between -$5.01 and -$5.01.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $6M in the next fiscal year. The high estimate is $6M and the low estimate is $6M. The average revenue growth estimate for next year is down -22.10% from the average revenue estimate for this year.
